Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2011, Article ID 267249, 8 pages
http://dx.doi.org/10.1155/2011/267249
Research Article

The Emergence of Clostridium difficile Infection among Peripartum Women: A Case-Control Study of a C. difficile Outbreak on an Obstetrical Service

1Department of Obstetrics and Gynecology, University of Washington, Seattle, P.O. Box 356460, WA 98195-6460, USA
2Department of Medicine, University of Washington Medical Center, Seattle, WA 98195-0001, USA

Received 1 November 2010; Revised 12 April 2011; Accepted 25 May 2011

Academic Editor: Patrick Ramsey

Copyright © 2011 Jennifer A. Unger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. A. Muto, M. Pokrywka, K. Shutt et al., “A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use,” Infection Control and Hospital Epidemiology, vol. 26, no. 3, pp. 273–280, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. J. G. Bartlett and D. N. Gerding, “Clinical recognition and diagnosis of Clostridium difficile infection,” Clinical Infectious Diseases, vol. 46, supplement 1, pp. S12–S18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. A. Miller, M. Hyland, M. Ofner-Agostini, M. Gourdeau, and M. Ishak, “Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals,” Infection Control and Hospital Epidemiology, vol. 23, no. 3, pp. 137–140, 2002. View at Google Scholar · View at Scopus
  4. V. G. Loo, L. Poirier, M. A. Miller et al., “A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality,” New England Journal of Medicine, vol. 353, no. 23, pp. 2442–2449, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. C. A. Muto, M. K. Blank, J. W. Marsh et al., “Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive “bundle” approach,” Clinical Infectious Diseases, vol. 45, no. 10, pp. 1266–1273, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. L. Kuntz, M. Yang, J. Cavanaugh, A. F. Saftlas, and P. M. Polgreen, “Trends in Clostridium difficile infection among peripartum women,” Infection Control and Hospital Epidemiology, vol. 31, no. 5, pp. 532–534, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. H. James, V. L. Katz, D. J. Dotters, and R. G. Rogers, “Clostridium difficile infection in obstetric and gynecologic patients,” Southern Medical Journal, vol. 90, no. 9, pp. 889–892, 1997. View at Google Scholar · View at Scopus
  8. “Severe Clostridium difficile-associated disease in populations previously at low risk—four states, 2005,” Morbidity and Mortality Weekly Report, vol. 54, no. 47, pp. 1201–1205, 2005.
  9. K. W. Garey, Z. D. Jiang, Y. Yadav, B. Mullins, K. Wong, and H. L. Dupont, “Peripartum Clostridium difficile infection: case series and review of the literature,” American Journal of Obstetrics and Gynecology, vol. 199, no. 4, pp. 332–337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. N. G. Rouphael, J. A. O'Donnell, J. Bhatnagar et al., “Clostridium difficile-associated diarrhea: an emerging threat to pregnant women,” American Journal of Obstetrics and Gynecology, vol. 198, no. 6, pp. 635.e1–635.e6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. G. Bartlett, “Narrative review: the new epidemic of Clostridium difficile-associated enteric disease,” Annals of Internal Medicine, vol. 145, no. 10, pp. 758–764, 2006. View at Google Scholar · View at Scopus
  12. S. H. Cohen, D. N. Gerding, S. Johnson et al., “Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA),” Infection Control and Hospital Epidemiology, vol. 31, no. 5, pp. 431–455, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. K. K. Lai, Z. S. Melvin, M. J. Menard, H. R. Kotilainen, and S. Baker, “Clostridium difficile-associated diarrhea: epidemiology, risk factors, and infection control,” Infection Control and Hospital Epidemiology, vol. 18, no. 9, pp. 628–632, 1997. View at Google Scholar · View at Scopus
  14. B. E. Hamilton, J. A. Martin, S. J. Ventura, P. D. Sutton, and F. Menacker, “Births: preliminary data for 2004,” National Vital Statistics Reports, vol. 54, no. 8, pp. 1–17, 2005. View at Google Scholar · View at Scopus
  15. A. Reingold, K. Gershman, S. Petit et al., “Perinatal group B streptococcal disease after universal screening recommendations—United States, 2003–2005,” Morbidity and Mortality Weekly Report, vol. 56, no. 28, pp. 701–705, 2007. View at Google Scholar · View at Scopus
  16. E. Lieberman, J. Lang, D. K. Richardson, F. D. Frigoletto, L. J. Heffner, and A. Cohen, “Intrapartum maternal fever and neonatal outcome,” Pediatrics, vol. 105, no. 1, part 1, pp. 8–13, 2000. View at Google Scholar · View at Scopus
  17. L. M. French and F. M. Smaill, “Antibiotic regimens for endometritis after delivery,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD001067, 2004. View at Google Scholar · View at Scopus
  18. M. C. Maberry, L. C. Gilstrap III, R. Bawdon, B. B. Little, and J. Dax, “Anaerobic coverage for intra-amnionic infection: maternal and perinatal impact,” American Journal of Perinatology, vol. 8, no. 5, pp. 338–341, 1991. View at Google Scholar · View at Scopus
  19. P. D. Stamper, R. Alcabasa, D. Aird et al., “Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples,” Journal of Clinical Microbiology, vol. 47, no. 2, pp. 373–378, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. R. S. Sperling, E. Newton, and R. S. Gibbs, “Intraamniotic infection in low-birth-weight infants,” Journal of Infectious Diseases, vol. 157, no. 1, pp. 113–117, 1988. View at Google Scholar · View at Scopus
  21. A. A. Venugopal, D. N. Gerding, and S. Johnson, “Clostridium difficile infection rates and spectrum of disease among peripartum women at one hospital from 2003 to 2007 with molecular typing analysis of recovered Clostridium difficile isolates,” American Journal of Infection Control, vol. 39, no. 3, pp. 206–211, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Valiquette, B. Cossette, M. P. Garant, H. Diab, and J. Pepin, “Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain,” Clinical Infectious Diseases, vol. 45, supplement 2, pp. S112–S121, 2007. View at Publisher · View at Google Scholar
  23. L. C. McDonald, G. E. Killgore, A. Thompson et al., “An epidemic, toxin gene-variant strain of Clostridium difficile,” New England Journal of Medicine, vol. 353, no. 23, pp. 2433–2441, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. R. C. Owens Jr, C. J. Donskey, R. P. Gaynes, V. G. Loo, and C. A. Muto, “Antimicrobial-associated risk factors for Clostridium difficile infection,” Clinical Infectious Diseases, vol. 46, supplement 1, pp. S19–S31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Pépin, N. Saheb, M. A. Coulombe et al., “Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec,” Clinical Infectious Diseases, vol. 41, no. 9, pp. 1254–1260, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Warny, J. Pepin, A. Fang et al., “Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe,” Lancet, vol. 366, no. 9491, pp. 1079–1084, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Pépin, L. Valiquette, M. E. Alary et al., “Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity,” Canadian Medical Association Journal, vol. 171, no. 5, pp. 466–472, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. D. N. Gerding, C. A. Muto, and R. C. Owens Jr, “Treatment of Clostridium difficile infection,” Clinical Infectious Diseases, vol. 46, supplement 1, pp. S32–S42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. L. C. McDonald, “Confronting Clostridium difficile in inpatient health care facilities,” Clinical Infectious Diseases, vol. 45, no. 10, pp. 1274–1276, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. J. G. Bartlett, “The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection,” Clinical Infectious Diseases, vol. 46, no. 10, pp. 1489–1492, 2008. View at Publisher · View at Google Scholar · View at Scopus